These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 27328306)
21. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566 [TBL] [Abstract][Full Text] [Related]
22. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Santucci C; Alexandru M; Chen X; Mellerio JE; Karagiannis SN; Jacków-Malinowska J Hum Immunol; 2024 May; 85(3):110805. PubMed ID: 38703415 [TBL] [Abstract][Full Text] [Related]
23. Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa. Cianfarani F; Zambruno G; Castiglia D; Odorisio T Am J Pathol; 2017 Jul; 187(7):1445-1453. PubMed ID: 28460207 [TBL] [Abstract][Full Text] [Related]
24. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Dang N; Murrell DF Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993 [TBL] [Abstract][Full Text] [Related]
25. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa. Kim M; Murrell DF Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672 [TBL] [Abstract][Full Text] [Related]
30. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector. Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967 [TBL] [Abstract][Full Text] [Related]
31. One Novel Frameshift Mutation on Exon 64 of COL7A1 Gene in an Iranian Individual Suffering Recessive Dystrophic Epidermolysis Bullosa. Khaniani MS; Sohrabi N; Derakhshan NM; Derakhshan SM Ann Clin Lab Sci; 2015; 45(5):582-4. PubMed ID: 26586712 [TBL] [Abstract][Full Text] [Related]
32. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Tolar J; Ishida-Yamamoto A; Riddle M; McElmurry RT; Osborn M; Xia L; Lund T; Slattery C; Uitto J; Christiano AM; Wagner JE; Blazar BR Blood; 2009 Jan; 113(5):1167-74. PubMed ID: 18955559 [TBL] [Abstract][Full Text] [Related]
33. Novel biallelic variants in COL7A1 cause recessive dystrophic epidermolysis bullosa. Yang N; Ma Y; Yao H; Chang Q; Zhang V; Liang Z; Cai X Mol Genet Genomic Med; 2020 Aug; 8(8):e1347. PubMed ID: 32537942 [TBL] [Abstract][Full Text] [Related]
34. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen. van den Akker PC; Mellerio JE; Martinez AE; Liu L; Meijer R; Dopping-Hepenstal PJ; van Essen AJ; Scheffer H; Hofstra RM; McGrath JA; Jonkman MF J Med Genet; 2011 Mar; 48(3):160-7. PubMed ID: 21113014 [TBL] [Abstract][Full Text] [Related]
35. Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes. Latella MC; Cocchiarella F; De Rosa L; Turchiano G; Gonçalves MAFV; Larcher F; De Luca M; Recchia A J Invest Dermatol; 2017 Apr; 137(4):836-844. PubMed ID: 28027893 [TBL] [Abstract][Full Text] [Related]
37. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression. Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952 [TBL] [Abstract][Full Text] [Related]
38. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa. Murauer EM; Gache Y; Gratz IK; Klausegger A; Muss W; Gruber C; Meneguzzi G; Hintner H; Bauer JW J Invest Dermatol; 2011 Jan; 131(1):74-83. PubMed ID: 20720561 [TBL] [Abstract][Full Text] [Related]
39. Generation of the induced pluripotent stem cell line (ZSPHARi001-A) from a patient with recessive dystrophic epidermolysis bullosa carrying compound heterozygous mutation in the COL7A1 gene. Zhang Y; Fan J; Lu G; Xu G; Lv Q Stem Cell Res; 2022 Apr; 60():102672. PubMed ID: 35121199 [TBL] [Abstract][Full Text] [Related]
40. A glycine substitution in the COL7A1 gene causes mild RDEB in a Pakistani family. Kraemer L; Wajid M; Christiano AM Eur J Dermatol; 2006; 16(6):615-9. PubMed ID: 17229600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]